RUSAL's Response to the Guinea Ebola Epidemic


As one of the largest investors in the Republic of Guinea, RUSAL reacted immediately to support the Guinean government in their fight against the Ebola virus. We helped build the Centre for epidemic and microbiological research and treatment (CEMRT) in the Kindia administrative region. In July 2017, alongisde the Ministry of Health of the Russian Federation, we helped launch the post-authorisation study of Russia's GamEvac-Combi vaccine at the CEMRT.